Sarcura appoints a new CTO to accelerate technological development and further strengthen the leadership team

July. 2023 / Company
Daniela Buchmayr

Austrian deep tech company Sarcura today announced that Gerald Kreindl has joined the executive team as Chief Technology Officer.

As CTO, Gerald is overseeing Sarcura’s research and development activities. Gerald brings over 20 years of experience leading and transforming research and development efforts, spanning basic research and technology development in the semiconductor and life-science sector.

“Sarcura’s ambition to go beyond incremental advancements will further reimagine cell therapy manufacturing and ultimately help to improve patient outcome and accessibility for cure. I look forward to leveraging my experience to bring the company’s cell therapy manufacturing vision to life.”

Gerald Kreindl, MBA

Chief Technology Officer, Sarcura


Prior to Sarcura, Gerald served eight years at Illumina, where he held various leadership positions in RnD to develop multiple technologies, manufacturing techniques, and strategies at the intersection between semiconductors and biotechnology, mainly for Illumina’s core consumables.

In addition, Gerald has multiple years of international management and leadership experience, developing and growing part of Illumina’s Advanced Devices teams in Europe, Singapore, and San Diego. During his last year at Illumina, Gerald served at Illumina’s Global Program Office, managing Illumina’s change management initiatives.

Before Illumina, Gerald served in various scientific, engineering, and business development roles at Schott Glass, EVG, and Sandoz, mainly focusing on life science, diagnostics, and consumer electronics technology development, productization, and business and market development.

Gerald earned a degree in Chemical Industrial Engineering from the Technical College in Wels, Austria, in 2001 and a Master of Business Administration for Biotechnology and Pharmaceutical Management from the Danube Business School in 2019. He holds more than 20 (pending and issued) patents and has written several journal publications.

“I am thrilled to have Gerald join our team as our new CTO, bringing a wealth of experience and a passion for pushing the boundaries of technology to drive our company’s growth and success.”

Daniela Buchmayr, Co-founder and CEO of Sarcura.


“Gerald’s vast experience in RnD and leadership will be a precious addition to Sarcura’s team and help us bring our developments to the next level.”

Erwin Gorjup, Co-founder of Sarcura

Sarcura, a Vienna-based deep tech startup, develops a manufacturing platform to scale advanced cell therapy manufacturing capacity >100x while improving product quality and reducing manufacturing costs. Sarcura utilizes leading-edge semiconductor technologies integrated into microfluidic cartridges to integrate process and product control in a fully automated manufacturing device.